1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with fluorobenzenes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, S; Kobori, T; Nakamoto, K; Tokuyama, S | 2 |
| Jia, D; Li, W; Lv, Y; Shu, W; Wu, N | 1 |
3 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and fluorobenzenes
| Article | Year |
|---|---|
Activation of ERM-family proteins via RhoA-ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Analgesia; Analgesics, Opioid; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytoskeletal Proteins; Drug Interactions; Etoposide; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileum; Membrane Proteins; Mice; Microfilament Proteins; Morphine; Protein Kinase Inhibitors; Pyrimidines; rho-Associated Kinases; rhoA GTP-Binding Protein; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Up-Regulation | 2013 |
Involvement of PtdIns(4,5)P2 in the regulatory mechanism of small intestinal P-glycoprotein expression.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Cytoskeletal Proteins; Enzyme Inhibitors; Etoposide; Fluorobenzenes; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileum; Immunoprecipitation; Intestinal Mucosa; Intestine, Small; Male; Membrane Proteins; Metabolic Networks and Pathways; Mice; Microfilament Proteins; Phosphatidylinositol 4,5-Diphosphate; Phosphotransferases (Alcohol Group Acceptor); Pyrimidines; rho-Associated Kinases; rhoA GTP-Binding Protein; Rosuvastatin Calcium; Sulfonamides | 2014 |
Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Apoptosis; Calcium Channel Blockers; Cardiotonic Agents; Drug Synergism; Enzyme Inhibitors; Fluorobenzenes; Heart; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Ventricular Function, Left | 2014 |